7 Intravascular Ultrasound
Principles and Clinical Applications
Technical Background
Gray-Scale Intravascular Ultrasound
Gray-scale intravascular ultrasound (IVUS) utilizes one or more miniaturized transducers secured at the end of a flexible catheter that is inserted into arteries for in vivo tomographic visualization of vascular anatomy. Intracoronary ultrasound has become the most commonly used form of intravascular imaging and is regularly employed to delineate plaque morphology and distribution, to assess angiographically ambiguous lesions, to assess atherosclerosis progression and regression, to guide transcatheter coronary intervention, and to assess mechanisms of restenosis (Fig. 7-1).1–2 The IVUS catheter is attached to either a portable or installed ultrasound machine through an interface that ensures sterility of the catheter and allows for motorized pullback. Motorized pullback of the IVUS catheter (or of the transducer within the catheter) at 0.5 mm/s or 1.0 mm/s allows calculation of lesion length and plaque volumes (necessary for progression/regression studies), ensures adequate time to visualize the lesion, and allows comparison between IVUS “runs” done at different times but with similar pullback speeds.
Image Formation
An IVUS image is formed when ultrasound bounces off the multiple layers of the artery and returns to the transducer.3 The coronary artery is a muscular vessel composed of three basic layers: intima, media, and adventitia (Fig. 7-2). The intima, only a few cells thick at birth, is the site of atherosclerotic plaque accumulation. The intima is directly surrounded by the media, a layer of predominately homogeneous smooth muscle cells that provides the artery with its vascular tone. The outermost layer is the adventitia. Each of these layers tends to have a different acoustic property, allowing each to be visualized separately. When ultrasound encounters the intima, there is a large change in acoustic impedance; and much of it is bounced back to the transducer and displayed as a single concentric echo. Unless the intima becomes extremely hard, such as with the formation of a calcified plaque, some ultrasound penetrates through to the media. Because the media is composed of homogeneous smooth muscle cells, it passes through with minimal reflection; thus the media appears as a dark zone devoid of echoes. The adventitia has numerous layers of collagen fibers and therefore is a highly reflective structure that appears bright. As a result of the different acoustic properties of each layer, the normal coronary artery has a three-layered appearance, which includes (1) a bright echo from the intima, (2) a dark zone from the media, and (3) bright echoes from the adventitia. Because the resolution of IVUS is approximately 100 to 120 µm, the intima has to be at least this thick to be visualized as a distinct structure. In Western society, most patients presenting to the cardiac catheterization laboratory have some diffuse thickening of the intima. But if the intima is truly disease free, as in a newborn, child, or adolescent, then the intima will be much thinner and below the resolution of IVUS so that the artery will appear as a monolayer (see Fig. 7-2).
Image Interpretation
The interpretation of an IVUS image involves only a few simple steps: (1) identify the IVUS catheter in the center of the screen, keeping in mind that the IVUS catheter is traveling down the blood-filled lumen; (2) identify the dark stripe of the media that tells the size of the artery in the absence atherosclerotic disease; (3) remember that all of the echoes within the media stripe represent intima or intimal (atherosclerotic) disease and (4) all of the echoes outside the media are adventitia (see Fig. 7-2).
The amount of ultrasound that reflects off of tissue depends on the acoustic impedance (density) of the tissue. This property provides IVUS with some ability to differentiate plaque of different compositions. Hard material (calcium or fibrotic plaque) will reflect more ultrasound and appear brighter, whereas soft plaque (fat) will not reflect the ultrasound and will appear dark. Calcium is so dense that no ultrasound penetrates to the deeper tissues and, thus, produces acoustic shadows; shadowing, along with the bright echoes is the hallmark of calcification. A conventional approach is to compare the overall brightness of the plaque to the surrounding adventitia. Plaque is typically characterized as hypoechoic if less dense than the adventitia, hyperechoic if more dense than the adventitia, calcified if bright with acoustic shadowing, or mixed. IVUS can detect dense calcium with high sensitivity and specificity,4–6 but its accuracy in identifying high-risk lipid rich plaque or even thrombus formation is poor.7 As shown in Figure 7-3, gray-scale IVUS can also detect two other types of high-risk plaques: (1) noncalcified attenuated plaque (which correlates with fibroatheroma) and (2) calcium nodules (calcium with a convex shape and irregular surface).8–10
Radiofrequency Ivus
Standard gray-scale IVUS is limited, in part, because it uses only the amplitude of reflected ultrasound to formulate the image. In an effort to improve on the qualitative assessment of the reflected ultrasound signal, Kawasaki and coworkers developed a plaque characterization algorithm called integrated backscatter IVUS using time domain information directly from the radiofrequency signal. This process has resulted in improved plaque characterization with a reported in vitro sensitivity of 90% and specificity or 92% for lipid-rich plaque.11
In a similar effort to improve plaque characterization, spectral analysis (virtual histology [VH]-IVUS) combines signal frequency and amplitude analysis to create an algorithm that detects fibrous tissue (dark green), fibrofatty (light green), necrotic core (red), and dense calcium (white). Reported sensitivity and specificity of VH-IVUS are 91.7% and 96.6% for identification of the lipid-rich necrotic core.12–14 However, VH-IVUS cannot detect thrombus (in fact, thrombus appears as either fibrotic or fibrofatty plaque depending on the age of the thrombus) and has not been validated for assessment of stent metal or intimal hyperplasia. VH-IVUS lesion phenotype has been classified as (1) VH thin-cap fibroatheroma, (2) thick-cap fibroatheroma, (3) pathologic intimal thickening, (4) fibrotic plaque, and (5) fibrocalcific plaque (Fig. 7-4). Fibrotic plaque has mainly fibrous tissue with less than 10% confluent necrotic core, less than 10% confluent dense calcium, less than 15% fibrofatty. Fibrocalcific plaque has mainly fibrous tissue with greater than 10% confluent dense calcium, but less than 10% confluent necrotic core. Pathologic intimal thickening has a mixture of all plaque components, but dominantly fibrofatty with less than 10% confluent necrotic core and less than 10% confluent dense calcium. Fibroatheroma (both VH thin-cap fibroatheroma and thick-cap fibroatheroma) has greater than 10% confluent necrotic core. Because the resolution of VH-IVUS is 150 to 250 µm, it is not possible to detect fibrous cap thickness less than 65 µm (the typical pathologic definition of a thin fibrous cap). Therefore, if there is greater than 30° of necrotic core abutting to the lumen in three consecutive slices, the fibroatheroma is classified as VH thin-cap fibroatheroma; otherwise, it is classified as thick-cap fibroatheroma.15
Ivus Versus Angiography
It has been verified in autopsy studies and other IVUS studies of healthy donors that most people have diffuse atherosclerotic disease throughout their arteries by midlife, and this disease often remains angiographically silent because of its diffuse nature. In addition to diffuse plaque, vascular remodeling is also responsible for the high prevalence of angiographically silent disease. Both pathology and IVUS studies have documented that coronary arteries will enlarge to accommodate focal plaque deposition in an attempt to maintain luminal integrity. Compensatory dilation of the arterial wall occurs in direct response to the accumulation of atherosclerotic plaque. An absolute reduction in lumen dimensions typically does not occur until the lesion occupies approximately 40% to 50% of the area within the internal elastic membrane (40% to 50% cross-sectional narrowing).16 As a result, most of the atherosclerotic burden is contained within angiographically normal reference segments.17
Clinical Applications
Safety
Three large studies have evaluated the safety of IVUS. Other than transient spasm, complications appear to be rare (Table 7-1).18–20
Assessment Of Stenosis Severity
Coronary angiography underestimates stenosis severity most markedly in vessels with 50% to 75% plaque burden (plaque area divided by arterial area) at necropsy and in patients with multivessel disease.21–25 Clinical events are determined by lumen size, not by the amount of plaque. Therefore, it is important to focus on accurate measurement of lumen dimensions and not to be distracted by the plaque burden. Plaque burden in patients with atherosclerosis tends to be large even in the absence of lumen compromise.
Studies performed more than 10 years ago suggested that an IVUS minimum lumen area (MLA) greater than 4 mm2 was a valid criterion for deferring an intervention based both on comparisons to physiologic measures and on follow-up data.26–29 This cutoff only applied to major epicardial vessels excluding the LMCA and excluding saphenous vein grafts. However, it was necessary to interrogate the lesion carefully to identify the image slice with the smallest lumen, especially in very focal stenoses. Once the smallest lumen is identified, careful measurement was required. Recently this cutoff has come under criticism for a number of reasons including the size of the vessels (studies were done mostly in large 3.5-mm vessels), the average MLA of the intermediate lesions studied (4 mm2), and the fact that these studies have been misinterpreted to suggest that lesions with an MLA below 4 mm2 justify stent implantation. For this reason, it is recommended that for major epicardial vessels excluding the LMCA, physiologic lesion assessment (using an intracoronary pressure wire and maximum hyperemia with intravenous adenosine to measure the fractional flow reserve) is a complementary approach to assess lesion severity.30
Assessment Of Lmca Disease
A high percentage of patients with angiographically “normal” LMCA with only nonsignificant stenosis have substantial disease by IVUS.31–34 Reasons for the discrepancy between angiography and necropsy or IVUS assessment of LMCA disease include the following: (1) diffuse atherosclerotic involvement affects the angiographic diameter stenosis (DS) calculation because of the lack of a normal reference segment; (2) a short LMCA also makes identification of a normal reference segment difficult; (3) unique geometric issues exist in LMCA disease (the correlation between angiography and necropsy or IVUS appears to be somewhat better in non-LMCA stenoses); and (4) there is significant interobserver and intraobserver variability in the angiographic assessment of LMCA disease.35–42 In fact, the LMCA is the coronary arterial segment with the greatest variability in angiographic assessment.